New Developments in Hemodynamic Monitoring by Scheeren, Thomas W. L. & Ramsay, Michael A. E.
 
 
 University of Groningen
New Developments in Hemodynamic Monitoring
Scheeren, Thomas W. L.; Ramsay, Michael A. E.
Published in:
Journal of cardiothoracic and vascular anesthesia
DOI:
10.1053/j.jvca.2019.03.043
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Scheeren, T. W. L., & Ramsay, M. A. E. (2019). New Developments in Hemodynamic Monitoring. Journal
of cardiothoracic and vascular anesthesia, 33, S67-S72. https://doi.org/10.1053/j.jvca.2019.03.043
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 26-12-2020
Journal of Cardiothoracic and Vascular Anesthesia 33 (2019) S67S72
Contents lists available at ScienceDirect
Journal of Cardiothoracic and Vascular Anesthesia





1053-0770/ 2019 ElThomas W.L. Scheeren, MD, PhD*,
1
, Michael A.E. Ramsay, MDy
*Department of Anesthesiology, University of Groningen, University Medical Center Groningen, Groningen,
Netherlands
yDepartment of Anesthesiology and Pain Management, Baylor University Medical Center, Dallas, TXHemodynamic monitoring is an essential part of the perioperative management of the cardiovascular patient. It helps to detect hemodynamic
alterations, diagnose their underlying causes, and optimize oxygen delivery to the tissues. Furthermore, hemodynamic monitoring is necessary
to evaluate the adequacy of therapeutic interventions such as volume expansion or vasoactive medications. Recent developments include the
move from static to dynamic variables to assess conditions such as cardiac preload and fluid responsiveness and the transition to less-invasive or
even noninvasive monitoring techniques, at least in the perioperative setting. This review describes the available techniques that currently are
being used in the care of the cardiovascular patient and discusses their strengths and limitations. Even though the thermodilution method remains
the gold standard for measuring cardiac output (CO), the use of the pulmonary artery catheter has declined over the last decades, even in the set-
ting of cardiovascular anesthesia. The transpulmonary thermodilution method, in addition to accurately measuring CO, provides the user with
some additional helpful variables, of which extravascular lung water is probably the most interesting. Less-invasive monitoring techniques use,
for example, pulse contour analysis to originate flow-derived variables such as stroke volume and CO from the arterial pressure signal, or they
may measure the velocity-time integral in the descending aorta to estimate the stroke volume, using, for example, the esophageal Doppler.
Completely noninvasive methods such as the volume clamp method use finger cuffs to reconstruct the arterial pressure waveform, from which
stroke volume and CO are calculated. All of these less-invasive CO monitoring devices have percentage errors around 40% compared with refer-
ence methods (thermodilution), meaning that the values are not interchangeable.
 2019 Elsevier Inc. All rights reserved.
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toring—improving outcomes and patient safety—are the rea-
sons new and better technologies are instituted after they are
developed. Clinicians believe that these technologies will
improve management of the patient under anesthesia and in
the intensive care unit by providing accurate information that
can be used to optimize care, provide early diagnosis, and pro-
vide feedback that the therapies instituted are improving the
perfusion of vital organs and the microcirculation such that the
physiological environment is maintained optimally. However,
accurate and predictive hemodynamic assessment may be dif-
ficult. Anticipating when deterioration is imminent is challeng-
ing because the etiology may be multifactorial and involveuests to Thomas W.L. Scheeren, MD, PhD, Department
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sevier Inc. All rights reserved.volume status; myocardial function; vascular tone; and patient
resilience, which is still very hard to assess. These monitors
are tested in clinical trials with the anticipation that they will
provide accuracy (truth) and precision (repeatability), but
sometimes they are “black boxes” as far as the user is con-
cerned.1 However, this is the cost of innovation, and industry
and scientists must be encouraged to continue to pursue novel
developments but test the outcomes clinically.The Move From Static to Dynamic Measurements
In the last century, monitoring has developed from initially
pressure focused and noninvasive (eg, finger on the pulse and
listening to heart and Korotkoff sounds) to invasive (eg, cen-
tral venous pressure, arterial pressure, and pulmonary artery
pressure). However, invasive technology is associated with
complications such as infection and perforation. In recent
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technology without losing significant accuracy and precision,
avoiding the complications of invasive monitors, and analyz-
ing flow and response to fluid therapy. In 1968 Prys-Roberts
commented on an observation made by Jarisch in 1928 that
flow is so much more difficult to measure than pressure but
adequate flow is vital for cellular well-being.2 Waveform
analysis of the pulse contour is used to calculate stroke vol-
ume and cardiac output (CO), and the effect of respiratory
variation on this waveform has been used to estimate fluid
responsiveness or where the patient’s volume status is placed
on the Frank-Starling curve.
The goal of patient-centered hemodynamic monitoring is to
make correct therapeutic decisions and optimize the cardiovas-
cular system in the patient undergoing surgery or intensive
care treatment. Perioperative acute kidney injury (AKI) is
associated with increased morbidity and mortality and until
recently has been underdiagnosed. It is estimated that between
22% and 57% of patients admitted to the intensive care unit
will develop AKI during their admission3 and that current AKI
classification underestimates long-term mortality.4 Early diag-
nosis has been helped by the development of new biomarkers5
so that effective preventive and therapeutic measures can be
developed. The avoidance of hypotension and renal hypoper-
fusion and the optimization of volume status are the goals for
preventing renal ischemia. Goal-directed fluid therapy guided
by dynamic variables such as the pleth variability index (PVI),
pulse pressure variation (PPV) and stroke volume variation
(SVV) has been developed to measure fluid responsiveness.6
The PVI is a measure of the dynamic changes in the perfusion
index that occur during 1 or more complete respiratory cycles
and is measured using pulse oximetry. This respiratory varia-
tion in the pulse oximeter waveform is strongly related to
changes in arterial pulse pressure, which is sensitive to
changes in ventricular preload in mechanically ventilated
patients and more recently has been shown to accurately pre-
dict fluid responsiveness.7-9 The traditional methods of mea-
suring cardiac preload still are used to predict volume
responsiveness, but multiple studies have shown inaccuracy in
these static variables, such as central venous pressure, pulmo-
nary artery occlusion pressure, left ventricular end-diastolic
dimensions, early or latediastolic wave ratio, and B-type
natriuretic peptide concentration, in demonstrating volume
responders from nonresponders.10-14 Dynamic tests that chal-
lenge the Frank-Starling curve may predict fluid responsive-
ness but are limited if spontaneous ventilation is present or
cardiac arrhythmias are occurring. However, a pulse pressure
variation (PPV) or PVI >13% is highly predictive of fluid
responsiveness in mechanically ventilated patients in sinus
rhythm. Goal-directed fluid management using PVI has been
demonstrated to reduce perioperative lactate levels compared
with standard measures, including central venous pressure,
blood pressure, and fluid challenge. The authors used a PVI
threshold of 14% to infuse volume.15
Central venous pressure is a helpful indicator of cardiac pre-
load, but not preload responsiveness, and depends on the shape
of the Frank-Starling curve, as do all static markers of preload.SVV and PPV are other minimally invasive or noninvasive
dynamic variables that can be used to guide fluid management.
These again are more accurate in mechanically ventilated
patients in sinus rhythm. Arterial pulse pressure (systolic
minus diastolic) is directly proportional to stroke volume. This
PPV reflects the magnitude of respiratory changes in stroke
volume and reflects the degree of preload responsiveness. This
has been well-demonstrated in patients on mechanical ventila-
tion with normal tidal volumes and sinus rhythm.16,17Transition to Minimally Invasive and Noninvasive
Hemodynamic Monitoring Techniques
There undoubtedly has been a trend in recent years from
more invasive hemodynamic monitoring tools and techniques
(eg, pulmonary artery catheter [PAC] for measuring CO,
mixed venous oxygen saturation, and pulmonary arterial pres-
sures), to less-invasive techniques (eg, CO monitoring using
arterial pressure waveform analysis or the esophageal Dopp-
ler), and even completely noninvasive techniques (eg, volume
clamp using finger cuffs, bioimpedance and bioreactance, car-
bon dioxide (CO2)-rebreathing, and pulse wave transit time).
This trend became possible through the technical development
of innovative devices that have penetrated the market with var-
iable success. The core question to be asked is whether less
invasiveness also is accompanied by less accuracy,18 which
would limit the use of these devices markedly.
Although the pulmonary thermodilution method using the
PAC remains the gold standard for measuring CO, the use of
these techniques has declined over the last decades.19,20 Rea-
sons for this include the lack of benefit to treatment algorithms
based on PAC measurements.21-23 This also holds true for the
population of high-risk patients undergoing cardiac surgery,
for which the PAC still is widely used.24
That is slightly different from the transpulmonary thermo-
dilution (TPTD) method, which, although invasive, only necessi-
tates the insertion of a central venous line and an arterial thermistor
catheter.25 CO measured using this method might be considered
interchangeable with that obtained by the gold standard (intermit-
tent thermodilution with the PAC).26 In addition to measuring CO
with intermittent thermodilution, TPTD systems also provide con-
tinuous CO measurements by pulse contour analysis (PCA), which
can be calibrated by measurements of bolus thermodilution,
increasing their accuracy. In addition to CO, TPTD systems pro-
vide the user with additional hemodynamic measurements, includ-
ing SVV and PPV, for assessing fluid responsiveness, global end-
diastolic volume for estimating cardiac preload, extravascular lung
water for quantifying pulmonary edema, pulmonary vascular per-
meability index for evaluating capillary leakage, and cardiac func-
tion index and ejection fraction as indicators of systolic pump
function of the heart. These measurements allow for a complete
hemodynamic evaluation of the patient experiencing shock, there-
fore TPTD is recommended for evaluating acute circulatory failure
that does not respond to initial therapy or that is associated with
acute respiratory distress syndrome.27 Of these multiple variables,
extravascular lung water is probably the most interesting because
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distress syndrome28 and with mortality in critically ill patients.29
Amongst the less-invasive hemodynamic monitoring tech-
nologies, those based on PCA are the most broadly used. PCA
basically transfers a pressure signal (the arterial pressure
waveform) into a flow signal. There are several monitors on
the market, each of which uses its own proprietary algorithm
for analyzing the pulse contour. The most common one uses
the FloTrac sensor (Edwards Lifesciences, Irvine, CA), which
can be connected to any arterial catheter on the patient side
and to either the Vigileo, EV1000, or Hemosphere as the mon-
itor (all Edwards Lifesciences). The system derives stroke vol-
ume from the pulse pressure of the arterial pulse wave after
correcting for the compliance and the resistance of the vascu-
lature. The accuracy of the CO measurements has been ques-
tioned, particularly in patients with low vascular resistance,
which has led to multiple software updates of the algorithm to
account for these problems. The results of the accuracy of CO
data were summarized for the first 3 software generations,
showing percentage error deviations from reference CO meas-
urements (mostly PAC or TPTD) ranging from 13% to as high
as 75%, depending on the setting.30 After publication of that
review, a fourth-generation software was released and tested,
concluding that the accuracy of CO values measured with this
version has improved greatly compared with previous versions
but still did not reach a clinically sufficient level (ie, a percent-
age error <30%).31-33
Another uncalibrated PCA system for monitoring CO is the
ProAQT/PulsioFlex system (Pulsion-Getinge, Feldkirchen,
Germany). It essentially uses the PCA-based algorithm of the
PiCCO system (Pulsion-Getinge), however, without the possi-
bility of external validation by TPTD. Data regarding the accu-
racy of this device are scarce but indicate that the ProAQT/
PulsioFlex did not reliably estimate the absolute values of
CO.34 In addition to the accuracy of an absolute CO value, one
might be also interested as to whether a monitoring device can
track changes in CO, such as after volume expansion or phar-
macological interventions. In this respect, both methods (ie,
FloTrac and ProAQT) perform better and reliably track these
changes.
Additional PCA-based CO monitoring systems include the
LiDCOrapid (LiDCO, London, UK) and the pressure record-
ing analytical method. Taken in summary, these minimally
invasive PCA-based technologies have a moderate accuracy
with a percentage error of 41.3% § 2.7%.35
The esophageal Doppler (Cardio Q; Deltex Medical, Chi-
chester, UK) measures blood flow in the descending aorta via
a flexible Doppler probe introduced into the esophagus of
anesthetized patients. Unlike transesophageal echocardiogra-
phy, the transducer is directed toward the descending aorta to
measure the stroke distance (ie, the velocity-time integral),
which then is used to estimate the stroke volume.36 The mean
percentage error for this device was 42.1% § 9.9%.35
Completely noninvasive hemodynamic monitoring methods
come into play when not even the placement of an arterial line
is considered necessary for patient care. These methods can be
used to measure not only blood pressure continuously, but alsoCO and dynamic preload variables.37 The first group of nonin-
vasive CO technologies is based on principles similar to the
PCA methods previously described, with the only difference
being the arterial pulse wave is obtained noninvasively.27 The
so-called volume clamp method uses finger cuffs and relies on
photoplethysmography to keep the finger blood volume con-
stant,38 as first described in 1967 by the Czech physiologist
Penaz. This way, the arterial pressure waveform can be recon-
structed and CO can be calculated using the CO-Trek algo-
rithm.39 This method was incorporated in the Nexfin monitor
(BMEYE, Amsterdam, Netherlands), which was adopted by
Edwards Lifesciences in 2014 and merchandised under the
name Clearsight. Because the technology has not changed,
results obtained with the Nexfin also are applicable to the
Clearsight system. Studies examining CO estimates by this
method show a percentage error ranging from 24% to 58%
(average 44%) compared with TPTD.40 A similar technology
is used in the CNAP monitor (CNSystems Medizintechnik
AG, Graz, Austria), which also has shown acceptable agree-
ment with reference CO obtained using TPTD.41 In a system-
atic review of noninvasive CO monitoring devices, the
noninvasive PCA showed a pooled percentage error of 45%.42
Other noninvasive CO monitors that are not based on PCA
include bioreactance and bioimpedance,43 partial CO2-
rebreathing,44 and pulse wave transit time. These methods
recently have been described in detail.38,45,46 In a recent meta-
analysis, percentage errors for these CO monitoring devices
were 42% for bioimpedance and bioreactance, 40% for CO2-
rebreathing, and 62% for pulse wave transit time.42
As stated by a recent expert panel, noninvasive hemody-
namic monitors increasingly are being used in the periopera-
tive setting and with further technological improvements have
the potential to become the hemodynamic monitoring of the
future. This is different for the intensive care unit setting for
patients experiencing shock, who necessitate arterial catheteri-
zation (eg, for blood sampling), and when abnormal vasomotor
states such as sepsis or hepatic failure limit the accuracy of CO
measurements.27 However, it must be mentioned that the
choice of a monitoring technique based on patient factors (eg,
comorbidities and risk of surgery) and the setting can be modi-
fied if the patient’s condition deteriorates (step up approach)
or improves (step down) with regard to invasiveness and conti-
nuity of measurements.47 In the near future, technical develop-
ments such as miniaturized and wearable sensors and wireless
monitoring will contribute to the widespread use of noninva-
sive hemodynamic monitoring technologies.48,49
Introduction of Artificial Intelligence to Predict
Hemodynamic Changes
Artificial intelligence, machine learning, big data, and pre-
dictive analytics are key words that infiltrate modern medicine
just as they do in any other technology-associated field of sci-
ence. These words describe a process of incorporating large
amounts of disparate data into a unified algorithm, which then
is used to predict and solve a clinical problem. Examples of
their application include image processing of radiographic
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automated echocardiogram interpretation,52 and text analysis
of clinical notes.53 The October 2018 issue of the journal Anes-
thesiology was dedicated to this topic, summarizing the first
applications to the specialty of anesthesiology and what prac-
ticing clinicians need to know.54 It states that machine learning
is a discipline within computer science used to analyze large
data sets (big data) and develop predictive models (or algo-
rithms). It is used to analyze and model complex associations
and relationship patterns between multiple variables that are
otherwise occult to the human eye, are more simplistic vision
interfaces such as patient data monitors, or go beyond the lim-
its of human understanding. The authors also depicted the
information flow within the predictive modeling process for
machine learning, using data sets for developing, training, and
testing the model, which finally is validated by an external
data set.54 The issue also contains 2 examples of applying
machine-learningbased predictive analytics to predict hypo-
tension, a clinically relevant problem that is associated with
unfavorable outcome such as myocardial and renal injury55,56
and even increased mortality.57,58
In the first article, Hatib et al. describe the development of
an algorithm to predict an upcoming hypotensive event
(defined as a mean arterial pressure <65 mmHg).59 The math-
ematical algorithm called the hypotention prediction index
(HPI) was developed by learning from almost 13,000 past
hypotensive events and more than 12,000 nonhypotensive
events, derived from large data sets of high-fidelity arterial
waveforms from almost 1,700 patients. Each of the arterial
waveforms were first separated into 5 phases (such as systolic
and diastolic, upstroke and decay), from which more than
3,000 waveform features were identified. By combining these
individual features, more than 2.6 million waveform
features were obtained, which then were reduced by selection
processes to 51 base features that were used for model train-
ing. Using the aforementioned approach, patient data were
split into a training and cross-validation cohort and an internal
validation cohort. In addition, prospective patient data from an
academic hospital were used for external validation. The
results showed that the HPI algorithm was able to predict
hypotension with high sensitivity and specificity up to 15
minutes before the actual hypotensive event occurred and that
it performed better than changes in mean arterial pressure did.
These results have been confirmed by a recent observational
study in 255 patients undergoing major surgery, which also
showed that the HPI algorithm performed better in predicting
an upcoming hypotensive event than any other commonly
measured hemodynamic variable did.60 The HPI thus may buy
time to take measures before the hypotensive event actually
occurs, which implies a change in current practice from reac-
tive to proactive blood pressure management. However, it
must be realized that not all hypotensive events are predictable
by examining the arterial waveform changes before the hypo-
tensive event. These events include sudden changes in blood
pressure as induced by vascular clamping, bolus administra-
tion of anesthetics, or activation of neuraxial blocks, just to
name a few.In the second example, Kendale et al. used a similar approach
to predict postinduction hypotension, defined as a mean arterial
pressure <55 mmHg occurring within 10 minutes after induction
of anesthesia.61 The authors used data from more than 13,000
patients undergoing general anesthesia, again split into a training
and test set, to compare the performance of different machine-
learning models. They found that postinduction hypotension
occurred in about 9% of patients and that the best prediction
models included the use of a gradient boosting machine with an
area under the receiver operating curve (AUC) of 0.76, which
then was used for further testing. This was followed by the model
using a different mean arterial pressure threshold of 65 mmHg
with an AUC of 0.72, the model using the need for administration
of vasopressors (AUC= 0.75) and the down-sampled training set
(AUC = 0.76). The study showed that machine-learning models
were feasible as a systematic approach to predict postinduction
hypotension.
Additional successful examples of the use of machine-lear-
ningbased algorithms in the field of anesthesiology include
the prediction of complications after surgery such as sepsis
and AKI,62 the prediction of mortality after cardiac surgery,63
and the prediction of postoperative pain and associated resour-
ces consumption.64,65 Also, in the intensive care unit setting,
predictive analytics based on hemodynamic variables have
been used to reduce the incidence of septic shock.66
In summary, even though artificial intelligence may not be
an ideal approach for all tasks, it may offer solutions to a num-
ber of clinical problems and outcomes, which due to their
complex nature, withstand the assault of sustained thinking
and conventional approaches. It bears, however, the hazard of
creating new black boxes when the algorithms lack transpar-
ency. Nevertheless, artificial intelligence has the potential to
be incorporated into clinical decision support systems and to
help clinicians adhere to practice guidelines at the bedside.
However, data to support the beneficial effect of such
approaches on patient outcome are lacking.Conclusions
New methods of hemodynamic monitoring have the potential
to improve management of the cardiovascular patient during
anesthesia and postoperative care because they provide accurate,
precise, and repeatable measurements that can be used to detect
hemodynamic alterations and their causes, optimize hemody-
namic conditions such as oxygen delivery to the tissues, and pro-
vide feedback on the adequacy of therapeutic interventions.
Recent developments include the move from static to dynamic
variables to assess for conditions such as cardiac preload and
fluid responsiveness and the transition to less-invasive monitoring
techniques, at least in the perioperative setting. Future objectives
include wearable sensors and wireless remote monitoring, broad-
ening continuous vital sign monitoring to lower care units such
as general hospital wards. Furthermore, the introduction of artifi-
cial intelligence and machine learning will, based on big data,
allow for predictive analytics of hemodynamic problems before
they actually occur.
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